T1	Disorder 15 33	serotonin toxicity
T2	Pharmacological_substance 84 113	serotonin reuptake inhibitors
N1000 	Reference T2 MeSH:D017367	serotonin reuptake inhibitors
T3	Disorder 160 168	delirium
N1 	Reference T3 UMLS:C0011206	delirium
T4	Disorder 253 261	delirium
N2 	Reference T4 UMLS:C0011206	delirium
T5	Disorder 333 341	delirium
N3 	Reference T5 UMLS:C0011206	delirium
T6	Disorder 352 370	serotonin toxicity
T7	Pharmacological_substance 408 418	paroxetine
N1001 	Reference T7 MeSH:D017374	paroxetine
T8	Pharmacological_substance 547 557	paroxetine
N1002 	Reference T8 MeSH:D017374	paroxetine
T9	Disorder 659 677	serotonin toxicity
T13	Disorder 1018 1036	serotonin toxicity
T14	Disorder 1154 1172	serotonin toxicity
T15	Pharmacological_substance 1256 1269	MAO inhibitor
N1003 	Reference T15 MeSH:D008996	MAO inhibitor
T17	Disorder 1373 1390	hypotensive shock
T18	Disorder 1457 1476	Alzheimer's disease
N4 	Reference T18 UMLS:C0002395	Alzheimer's disease
T19	Disorder 1481 1488	malaria
N5 	Reference T19 UMLS:C0024530	malaria
T20	Disorder 1572 1590	serotonin toxicity
T10	Combination 44 61	co-administration
T23	Pharmacological_substance 65 79	methylene blue
N1004 	Reference T23 MeSH:D008751	methylene blue
T24	Speculation_cue 0 4	Risk
T31	Pharmacological_substance 562 576	other agent(s)
T32	Disorder 603 614	anaesthesia
N6 	Reference T32 UMLS:C0278134	anaesthesia
T36	Pharmacological_substance 830 844	methylene blue
N1005 	Reference T36 MeSH:D008751	methylene blue
T39	Pharmacological_substance 914 928	Methylene blue
N1006 	Reference T39 MeSH:D008751	Methylene blue
T42	Speculation_cue 1047 1055	reported
T43	Pharmacological_substance 1271 1285	Methylene blue
N1007 	Reference T43 MeSH:D008751	Methylene blue
T44	Disorder 1395 1413	methemoglobinaemia
T48	Pharmacological_substance 1536 1550	methylene blue
N1008 	Reference T48 MeSH:D008751	methylene blue
T16	Coreferring_mention 1415 1417	It
T25	Speculation_cue 1432 1439	studied
